Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo
Serious adverse events · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower serious adverse events compared with conventional western medicine (CWM) plus placebo (high certainty).
1 finding from 1 review
- Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease 2013 · Cochrane Headline outcomes onlyRR 0.45 [0.28, 0.7]2 studies · 432 participantsHigh